Segment disclosures

Company overview

Perspective Therapeutics, Inc.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

2 dimension combinations 20 retained observations 6 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Operating Segments · Brachytherapy Segment

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=catx:BrachytherapySegmentMember
PeriodValueUnitFiledEvidence
2023-07-01 – 2023-09-301909000 USD20231114Open filing evidence
2023-01-01 – 2023-09-305239000 USD20231114Open filing evidence
2023-04-01 – 2023-06-301500000 USD20230811Open filing evidence
2023-01-01 – 2023-06-303330000 USD20230811Open filing evidence
2023-01-01 – 2023-03-311830000 USD20230515Open filing evidence
2022-07-01 – 2022-09-301717000 USD20231114Open filing evidence
2022-01-01 – 2022-09-307132000 USD20231114Open filing evidence
2022-04-01 – 2022-06-302505000 USD20230811Open filing evidence
2022-01-01 – 2022-06-305415000 USD20230811Open filing evidence
2022-01-01 – 2022-03-312910000 USD20230515Open filing evidence

Operating Segments · Drug Operations Segment

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=catx:DrugOperationsSegmentMember
PeriodValueUnitFiledEvidence
2023-07-01 – 2023-09-30276000 USD20231114Open filing evidence
2023-01-01 – 2023-09-301097000 USD20231114Open filing evidence
2023-04-01 – 2023-06-30588000 USD20230811Open filing evidence
2023-01-01 – 2023-06-30821000 USD20230811Open filing evidence
2023-01-01 – 2023-03-31233000 USD20230515Open filing evidence
2022-07-01 – 2022-09-300 USD20231114Open filing evidence
2022-01-01 – 2022-09-300 USD20231114Open filing evidence
2022-04-01 – 2022-06-300 USD20230811Open filing evidence
2022-01-01 – 2022-06-300 USD20230811Open filing evidence
2022-01-01 – 2022-03-310 USD20230515Open filing evidence